Stefan Aebi Selected Research

Stefan Aebi Research Topics

Disease

28	Breast Neoplasms (Breast Cancer) 08/2023 - 01/2004
22	Neoplasms (Cancer) 08/2023 - 12/2003
3	Disease Progression 09/2019 - 06/2004
3	Amenorrhea 01/2007 - 12/2003
2	Multiple Myeloma 01/2023 - 04/2022
2	Melanoma (Melanoma, Malignant) 04/2022 - 02/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2018 - 06/2002
2	Lung Neoplasms (Lung Cancer) 04/2015 - 01/2015
2	Adenocarcinoma of Lung 05/2013 - 10/2012
1	Neoplasm Metastasis (Metastasis) 08/2023
1	Inflammatory Breast Neoplasms 03/2022
1	Brain Neoplasms (Brain Tumor) 06/2019
1	Meningeal Carcinomatosis 11/2018
1	Sarcoma (Soft Tissue Sarcoma) 04/2018
1	Fibrosarcoma 04/2018
1	Adenocarcinoma 04/2018
1	Skin Neoplasms (Skin Cancer) 02/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 02/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Thymoma (Thymic Carcinoma) 12/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Osteoporosis 04/2014
1	Margins of Excision 02/2014
1	Unilateral Breast Neoplasms 02/2014
1	Nausea 01/2012
1	Vomiting 01/2012
1	Cicatrix (Scar) 11/2008
1	Dihydropyrimidine Dehydrogenase Deficiency 10/2008
1	Anemia 01/2008
1	Hot Flashes 01/2007

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 01/2021 - 12/2003
5	Trastuzumab (Herceptin)FDA Link 09/2019 - 06/2008
5	Estrogen ReceptorsIBA 02/2016 - 12/2005
4	RNA (Ribonucleic Acid)IBA 08/2023 - 04/2008
4	Progesterone Receptors (Progesterone Receptor)IBA 08/2023 - 12/2003
4	Letrozole (Femara)FDA LinkGeneric 01/2021 - 01/2018
4	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 06/2002
4	Tamoxifen FDA LinkGeneric 02/2016 - 06/2004
3	Capecitabine (Xeloda)FDA Link 11/2020 - 01/2004
3	ErbB Receptors (EGF Receptor)IBA 04/2018 - 01/2007
2	Estrogens (Estrogen)FDA Link 08/2022 - 12/2003
2	VemurafenibIBA 04/2022 - 10/2012
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2022 - 10/2008
2	ParaffinIBA 06/2019 - 04/2008
2	Formaldehyde (Formol)FDA Link 06/2019 - 04/2008
2	LigandsIBA 02/2018 - 03/2006
2	Aromatase InhibitorsIBA 01/2018 - 02/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007 - 01/2006
2	Methotrexate (Mexate)FDA LinkGeneric 01/2007 - 09/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2006 - 01/2004
1	Estrogen Receptor alphaIBA 08/2023
1	Progesterone FDA LinkGeneric 08/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2023
1	eribulin FDA Link 01/2023
1	pomalidomideIBA 01/2023
1	trametinibIBA 04/2022
1	dabrafenibIBA 04/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	ProdrugsIBA 11/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2020
1	Thymidylate SynthaseIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 04/2018
1	human ERBB2 proteinIBA 04/2018
1	NivolumabIBA 02/2018
1	Death Domain ReceptorsIBA 02/2018
1	pembrolizumabIBA 12/2016
1	Ado-Trastuzumab EmtansineIBA 04/2015
1	Gefitinib (Iressa)FDA Link 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	OsteocalcinIBA 04/2014
1	Alkaline PhosphataseIBA 04/2014
1	collagen type I trimeric cross-linked peptideIBA 04/2014
1	vandetanib (ZD6474)IBA 05/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2010
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 10/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2010
1	DNA (Deoxyribonucleic Acid)IBA 10/2010
1	Diphosphonates (Bisphosphonates)IBA 04/2010
1	Zoledronic Acid (Zometa)FDA Link 05/2009
1	pyrimidineIBA 10/2008
1	EnzymesIBA 10/2008
1	Hemoglobins (Hemoglobin)IBA 01/2008
1	taxaneIBA 01/2008
1	Goserelin (Zoladex)FDA Link 01/2007
1	Phosphotransferases (Kinase)IBA 01/2007
1	VaccinesIBA 01/2007
1	Tyrosine (L-Tyrosine)FDA Link 01/2007
1	Monoclonal AntibodiesIBA 01/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007
1	Filgrastim (Neupogen)FDA Link 01/2006

Therapy/Procedure

19	Therapeutics 01/2021 - 12/2003
18	Drug Therapy (Chemotherapy) 09/2019 - 06/2002
6	Adjuvant Chemotherapy 02/2014 - 03/2006
5	Radiotherapy 01/2018 - 06/2002
4	Mastectomy (Mammectomy) 03/2022 - 06/2008
3	Segmental Mastectomy (Lumpectomy) 02/2014 - 06/2008
1	Neoadjuvant Therapy 03/2022